SIDEBAR
»
S
I
D
E
B
A
R
«
Healthcare reform’s most unlikely winner: India
Nov 4th, 2013 by Warren Swil

Country’s pharmaceutical

industry eyes vast expansion

Ernst and Young Analyst Muralidharan Nair spoke about the boon to India.

WHILE MOST MEDIA and Republicans seem obsessed with the problems related to the rollout of healthcare reform, a few entities are rejoicing.
They are about to become very rich – or, in some cases, even richer.
There are some obvious beneficiaries. Giant insurance companies, for instance, which will enroll millions of new customers.
There are other less obvious ones, like the start-ups hoping to take advantage of the new healthcare rules.
But, the most surprising one of all, however, is not even in America.
India and its pharmaceutical industry is gearing up for a massive expansion as millions of new prescriptions are written for generic drugs covered under the new insurance policies.


Read the rest of this entry »
SIDEBAR
»
S
I
D
E
B
A
R
«
»  Substance: WordPress   »  Style: Ahren Ahimsa & Martin Black